Trial intelligence / Profile preview

Dydrogesterone versus Guizhi Fuling Capsules for dysmenorrhea

ChiCTR2100043308Phase 4Recruiting

Sponsor
Guangdong Women and Children Hospital
Start
Feb 2021
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in dysmenorrhea comparing Dydrogesterone treatment group with Guizhi Fuling Capsules treatment group (2 arms). Primary endpoint: Visual Analogue Scale. Started Feb 2021; status: recruiting.

02

Drugs

dydrogesteroneguizhi fuling capsule
03

Conditions

dysmenorrhea

Beyond the preview

Go deeper on ChiCTR2100043308.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100043308.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call